Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant Recipients”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00537862
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)UnknownNCT01744470
What this trial is testing

Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

Who this might be right for
De Novo Transplant Disease
University Hospital, Tours 286
Testing effectiveness (Phase 2)Study completedNCT00483756
What this trial is testing

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer 338
Large-scale testing (Phase 3)Study completedNCT00189202
What this trial is testing

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Who this might be right for
End Stage Renal DiseaseKidney Transplantation
University of Michigan 49
Post-approval studies (Phase 4)Study completedNCT01706471
What this trial is testing

Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

Who this might be right for
Planned Kidney Transplantation
Yonsei University 60
Post-approval studies (Phase 4)Study completedNCT00371826
What this trial is testing

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Who this might be right for
Renal Transplanted Recipients
Novartis Pharmaceuticals 126
Post-approval studies (Phase 4)Study completedNCT00195468
What this trial is testing

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 280
Post-approval studies (Phase 4)Study completedNCT00312143
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
De Novo Kidney Transplant Recipients
Novartis 35
Large-scale testing (Phase 3)Study completedNCT00167947
What this trial is testing

Study Evaluating Sirolimus in Kidney Transplant Recipients.

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 150
Large-scale testing (Phase 3)Study completedNCT00658320
What this trial is testing

Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

Who this might be right for
Kidney Transplantation
Novartis 122
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Large-scale testing (Phase 3)Study completedNCT00308425
What this trial is testing

Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

Who this might be right for
De Novo Renal Transplantation
Novartis 119
Large-scale testing (Phase 3)Study completedNCT01410448
What this trial is testing

Everolimus in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 383
Not applicableLooking for participantsNCT07081126
What this trial is testing

Daratumumab for Late Antibody-Mediated Rejection

Who this might be right for
Kidney TansplantAcute Rejection (AR) of Transplanted Kidney
University Hospital, Martin 20
Post-approval studies (Phase 4)Study completedNCT05153915
What this trial is testing

Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 56
Post-approval studies (Phase 4)UnknownNCT05872568
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Zhishui Chen 270
Not applicableEnded earlyNCT01609673
What this trial is testing

Study of Everolimus in de Novo Renal Transplant Recipients

Who this might be right for
End Stage Renal Failure With Renal Transplant
Helady Pinheiro, MD, PhD 1
Large-scale testing (Phase 3)Study completedNCT00098241
What this trial is testing

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 45
Post-approval studies (Phase 4)Study completedNCT00170885
What this trial is testing

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis
Post-approval studies (Phase 4)Study completedNCT00229138
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 291
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation